The documents below are related to the City of Philadelphia’s academic detailing campaign promoting naloxone co-prescribing by healthcare providers in Philadelphia.
Evaluation of public health detailing visit: If you have participated in a public health detailing visit, please complete this brief evaluation, led by the University of Pittsburgh. It will take less than 5 minutes and all responses are anonymous. Thank you for your time.
| Name | Description | Released | Format |
|---|---|---|---|
| Introductory Cover Letter PDF | March 29, 2022 | ||
| Prescription Opioid and Benzodiazepine Use in Philadelphia, 2017 PDF | March 11, 2022 | ||
| Unintentional Overdose Fatalities in Philadelphia, 2020 PDF | March 11, 2022 | ||
| Health Alert – Counterfeit Pills, 2020 PDF | March 11, 2022 | ||
| Prescribing Guidance for Clinical Settings PDF | March 11, 2022 | ||
| Talking to Patients About Naloxone PDF | March 16, 2022 | ||
| Prescribing Naloxone to Patients PDF | March 16, 2022 | ||
| For Patients – Getting Naloxone in Pharmacies FAQ PDF | March 11, 2022 | ||
| For Patients – Pennsylvania Naloxone Copay Assistance Program PDF | March 11, 2022 | ||
| Study of Naloxone Coprescription for Patients Receiving Long-Term Opioid Therapy for Pain (Annals of Internal Medicine) PDF | March 11, 2022 |